• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Opinion

Video

Treatment Switches and the Future of Hidradenitis Suppurativa Management

Author(s):

Jennifer Hsiao, MD,Rani Cooper, MD

Panelists discuss how identifying optimal timing for treatment switches and emerging therapeutic innovations are reshaping the management landscape for hidradenitis suppurativa, with the potential to improve long-term patient outcomes.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Related Videos
      1 expert in this video
      Personalized Photoprotection Based on Patient Factors
      1 expert in this video
      Impact of Oxidative Stress on Skin Health and the Utility of Antioxidants
      1 expert in this video
      Laboratory Monitoring for JAK Inhibitors and Key Takeaways
      1 expert in this video
      Options for Eyebrow and Eyelash Regrowth in a 32-Year-Old Female With Alopecia Areata
      4 experts are featured in this series.
      Efficacy, Safety, and Role in Therapy of JAK Inhibitors for Atopic Dermatitis
      4 experts are featured in this series.
      The Impact of JAK Selectivity in Atopic Dermatitis Treatment
      1 expert is featured in this series.
      Recapping the Evolving Treatment Landscape for Atopic Dermatitis
      1 expert in this video
      Sunscreen Ingredients for UV and Visible Light Protection
      1 expert in this video
      The Solar Spectrum and Impact on Skin Health
      1 expert in this video
      Discussing Efficacy and Safety of JAK Inhibitors With Patients and Caregivers
      Related Content
      Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 1
      March 18th 2025

      Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 1

      The Cutaneous Connection: Episode 1- Cannabinoid Use in Dermatology
      June 25th 2020

      The Cutaneous Connection: Episode 1- Cannabinoid Use in Dermatology

      Amlitelimab Demonstrates Durable Response in Atopic Dermatitis
      March 14th 2025

      Amlitelimab Demonstrates Durable Response in Atopic Dermatitis

      Key Insights from Novartis at AAD and AAAAI: Flexibility and Personalization in Dermatology Treatment
      March 14th 2025

      Key Insights from Novartis at AAD and AAAAI: Flexibility and Personalization in Dermatology Treatment

      InflaRX Presents Efficacy and Safety Data on Vilobelimab at AAD 2025
      March 11th 2025

      InflaRX Presents Efficacy and Safety Data on Vilobelimab at AAD 2025

      Jeff Stark, MD: Discussing Bimzelx’s Efficacy and Future in Treating Inflammatory Skin Diseases
      March 10th 2025

      Jeff Stark, MD: Discussing Bimzelx’s Efficacy and Future in Treating Inflammatory Skin Diseases

      © 2025 MJH Life Sciences

      All rights reserved.